FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1966307963> ?p ?o ?g. }

• W1966307963 endingPage "e915" @default.
• W1966307963 startingPage "e915" @default.
• W1966307963 abstract "The phenotypic transformation of well-differentiated epithelial carcinoma into a mesenchymal-like state provides cancer cells with the ability to disseminate locally and to metastasise. Different degrees of epithelial-mesenchymal transition (EMT) have been found to occur in carcinomas from breast, colon and ovarian carcinoma (OC), among others. Numerous studies have focused on bona fide epithelial and mesenchymal states but rarely on intermediate states. In this study, we describe a model system for appraising the spectrum of EMT using 43 well-characterised OC cell lines. Phenotypic EMT characterisation reveals four subgroups: Epithelial, Intermediate E, Intermediate M and Mesenchymal, which represent different epithelial-mesenchymal compositions along the EMT spectrum. In cell-based EMT-related functional studies, OC cells harbouring an Intermediate M phenotype are characterised by high N-cadherin and ZEB1 expression and low E-cadherin and ERBB3/HER3 expression and are more anoikis-resistant and spheroidogenic. A specific Src-kinase inhibitor, Saracatinib (AZD0530), restores E-cadherin expression in Intermediate M cells in in vitro and in vivo models and abrogates spheroidogenesis. We show how a 33-gene EMT Signature can sub-classify an OC cohort into four EMT States correlating with progression-free survival (PFS). We conclude that the characterisation of intermediate EMT states provides a new approach to better define EMT. The concept of the EMT Spectrum allows the utilisation of EMT genes as predictive markers and the design and application of therapeutic targets for reversing EMT in a selective subgroup of patients." @default.
• W1966307963 created "2016-06-24" @default.
• W1966307963 creator A5006560100 @default.
• W1966307963 creator A5007376349 @default.
• W1966307963 creator A5012129012 @default.
• W1966307963 creator A5012262880 @default.
• W1966307963 creator A5013058856 @default.
• W1966307963 creator A5014898667 @default.
• W1966307963 creator A5032899537 @default.
• W1966307963 creator A5039283945 @default.
• W1966307963 creator A5040624494 @default.
• W1966307963 creator A5045972854 @default.
• W1966307963 creator A5050120386 @default.
• W1966307963 creator A5050768342 @default.
• W1966307963 creator A5060869211 @default.
• W1966307963 creator A5075249092 @default.
• W1966307963 creator A5075507099 @default.
• W1966307963 creator A5079451508 @default.
• W1966307963 creator A5082910812 @default.
• W1966307963 date "2013-11-01" @default.
• W1966307963 modified "2023-10-10" @default.
• W1966307963 title "An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530)" @default.
• W1966307963 cites W1590620730 @default.
• W1966307963 cites W1964081206 @default.
• W1966307963 cites W1964825240 @default.
• W1966307963 cites W1965136174 @default.
• W1966307963 cites W1965568527 @default.
• W1966307963 cites W1976324983 @default.
• W1966307963 cites W1977478458 @default.
• W1966307963 cites W1982736212 @default.
• W1966307963 cites W1984326475 @default.
• W1966307963 cites W1984469163 @default.
• W1966307963 cites W1985222251 @default.
• W1966307963 cites W1994115546 @default.
• W1966307963 cites W2001751386 @default.
• W1966307963 cites W2005436781 @default.
• W1966307963 cites W2013625721 @default.
• W1966307963 cites W2014691022 @default.
• W1966307963 cites W2019237060 @default.
• W1966307963 cites W2025647419 @default.
• W1966307963 cites W2029209435 @default.
• W1966307963 cites W2037583144 @default.
• W1966307963 cites W2042965279 @default.
• W1966307963 cites W2048326490 @default.
• W1966307963 cites W2056430416 @default.
• W1966307963 cites W2069312908 @default.
• W1966307963 cites W2070755882 @default.
• W1966307963 cites W2071140324 @default.
• W1966307963 cites W2076036054 @default.
• W1966307963 cites W2076583198 @default.
• W1966307963 cites W2077462602 @default.
• W1966307963 cites W2087312216 @default.
• W1966307963 cites W2095927032 @default.
• W1966307963 cites W2098455835 @default.
• W1966307963 cites W2100751052 @default.
• W1966307963 cites W2101136328 @default.
• W1966307963 cites W2109023646 @default.
• W1966307963 cites W2113514001 @default.
• W1966307963 cites W2114154136 @default.
• W1966307963 cites W2117692326 @default.
• W1966307963 cites W2121389240 @default.
• W1966307963 cites W2123696077 @default.
• W1966307963 cites W2123998270 @default.
• W1966307963 cites W2124559417 @default.
• W1966307963 cites W2131593373 @default.
• W1966307963 cites W2133735831 @default.
• W1966307963 cites W2133994290 @default.
• W1966307963 cites W2137022580 @default.
• W1966307963 cites W2140551998 @default.
• W1966307963 cites W2142426658 @default.
• W1966307963 cites W2142739240 @default.
• W1966307963 cites W2144884298 @default.
• W1966307963 cites W2147478966 @default.
• W1966307963 cites W2149477979 @default.
• W1966307963 cites W2151981428 @default.
• W1966307963 cites W2152625770 @default.
• W1966307963 cites W2153954746 @default.
• W1966307963 cites W2165781226 @default.
• W1966307963 cites W2166649117 @default.
• W1966307963 cites W2168887286 @default.
• W1966307963 cites W2170556339 @default.
• W1966307963 cites W2333150484 @default.
• W1966307963 doi "https://doi.org/10.1038/cddis.2013.442" @default.
• W1966307963 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3847320" @default.
• W1966307963 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24201814" @default.
• W1966307963 hasPublicationYear "2013" @default.
• W1966307963 type Work @default.
• W1966307963 sameAs 1966307963 @default.
• W1966307963 citedByCount "339" @default.
• W1966307963 countsByYear W19663079632014 @default.
• W1966307963 countsByYear W19663079632015 @default.
• W1966307963 countsByYear W19663079632016 @default.
• W1966307963 countsByYear W19663079632017 @default.
• W1966307963 countsByYear W19663079632018 @default.
• W1966307963 countsByYear W19663079632019 @default.
• W1966307963 countsByYear W19663079632020 @default.
• W1966307963 countsByYear W19663079632021 @default.
• W1966307963 countsByYear W19663079632022 @default.

• next